ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,030 filers reported holding ASTRAZENECA PLC in Q1 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,522,493 | +4.2% | 155,377 | +10.2% | 0.02% | +6.2% |
| Q2 2023 | $10,095,163 | +2.8% | 141,053 | -0.3% | 0.02% | -5.9% |
| Q1 2023 | $9,819,017 | +28.4% | 141,464 | +25.5% | 0.02% | +21.4% |
| Q4 2022 | $7,645,021 | +14.9% | 112,758 | -7.1% | 0.01% | 0.0% |
| Q3 2022 | $6,656,000 | -21.3% | 121,389 | -5.2% | 0.01% | -12.5% |
| Q2 2022 | $8,462,000 | +9.3% | 128,070 | +9.7% | 0.02% | +23.1% |
| Q1 2022 | $7,745,000 | +31.8% | 116,733 | +15.7% | 0.01% | +44.4% |
| Q4 2021 | $5,875,000 | -3.9% | 100,863 | -0.9% | 0.01% | -18.2% |
| Q3 2021 | $6,112,000 | +37.3% | 101,758 | +36.9% | 0.01% | +37.5% |
| Q2 2021 | $4,451,000 | +26.0% | 74,314 | +4.6% | 0.01% | +14.3% |
| Q1 2021 | $3,533,000 | -8.0% | 71,040 | -7.5% | 0.01% | -12.5% |
| Q4 2020 | $3,840,000 | -4.0% | 76,804 | +5.3% | 0.01% | -20.0% |
| Q3 2020 | $3,999,000 | -11.9% | 72,964 | -15.0% | 0.01% | -16.7% |
| Q2 2020 | $4,538,000 | +16.5% | 85,832 | -1.6% | 0.01% | 0.0% |
| Q1 2020 | $3,894,000 | -10.0% | 87,203 | +0.5% | 0.01% | +9.1% |
| Q4 2019 | $4,326,000 | +11.2% | 86,773 | -0.6% | 0.01% | 0.0% |
| Q3 2019 | $3,891,000 | +69.9% | 87,312 | +57.4% | 0.01% | +83.3% |
| Q2 2019 | $2,290,000 | +9.6% | 55,489 | +7.4% | 0.01% | 0.0% |
| Q1 2019 | $2,089,000 | -16.7% | 51,664 | -21.8% | 0.01% | -25.0% |
| Q4 2018 | $2,507,000 | -1.8% | 66,030 | +2.4% | 0.01% | +14.3% |
| Q3 2018 | $2,552,000 | +12.7% | 64,473 | -0.0% | 0.01% | 0.0% |
| Q2 2018 | $2,264,000 | -7.8% | 64,490 | -8.1% | 0.01% | -12.5% |
| Q1 2018 | $2,455,000 | +9.6% | 70,212 | +8.8% | 0.01% | +14.3% |
| Q4 2017 | $2,240,000 | +13.8% | 64,561 | +11.1% | 0.01% | +16.7% |
| Q3 2017 | $1,969,000 | +6.4% | 58,108 | +7.1% | 0.01% | 0.0% |
| Q2 2017 | $1,851,000 | -5.0% | 54,279 | -13.2% | 0.01% | -14.3% |
| Q1 2017 | $1,949,000 | -28.6% | 62,569 | -37.3% | 0.01% | -30.0% |
| Q4 2016 | $2,729,000 | -29.0% | 99,859 | -14.6% | 0.01% | -28.6% |
| Q3 2016 | $3,843,000 | -9.8% | 116,925 | -17.1% | 0.01% | -12.5% |
| Q2 2016 | $4,261,000 | +37.1% | 141,128 | +27.9% | 0.02% | +33.3% |
| Q1 2016 | $3,108,000 | -27.8% | 110,350 | -13.0% | 0.01% | -29.4% |
| Q4 2015 | $4,304,000 | +15.5% | 126,767 | +8.2% | 0.02% | +6.2% |
| Q3 2015 | $3,727,000 | +18.0% | 117,129 | +136.2% | 0.02% | +33.3% |
| Q2 2015 | $3,159,000 | +15.9% | 49,587 | +24.5% | 0.01% | +20.0% |
| Q1 2015 | $2,726,000 | -33.8% | 39,839 | -31.9% | 0.01% | -37.5% |
| Q4 2014 | $4,118,000 | -18.4% | 58,511 | -17.2% | 0.02% | -20.0% |
| Q3 2014 | $5,049,000 | -24.5% | 70,666 | -21.5% | 0.02% | -25.9% |
| Q2 2014 | $6,690,000 | -26.4% | 90,033 | -35.7% | 0.03% | -27.0% |
| Q1 2014 | $9,086,000 | +30.2% | 140,037 | +19.1% | 0.04% | +32.1% |
| Q4 2013 | $6,978,000 | +22.7% | 117,531 | +7.3% | 0.03% | +12.0% |
| Q3 2013 | $5,687,000 | +20.9% | 109,507 | +10.1% | 0.02% | +19.0% |
| Q2 2013 | $4,705,000 | – | 99,457 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |